Anthropic’s standing is unusually strong but contested: the company reports more than $70 billion in ARR, has generated working exploit chains across five named platforms, and was linked to a remote-access trojan reaching developer laptops worldwide. Watch the pending IPO, which has attracted tens of millions of dollars in prediction-market volume and positioned Amazon for especially large gains, alongside enterprise-cost tools, agentic drug-development results, and efforts to clarify potentially uninsurable AI risks.